Lia Malettou

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. pmc Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
    George Pentheroudakis
    Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece
    BMC Cancer 13:49. 2013
  2. pmc Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial
    Helen Gogas
    First Department of Medicine, University of Athens, Medical School, Athens, Greece
    J Transl Med 8:108. 2010
  3. pmc A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
    Dimitrios Bafaloukos
    1st Oncology Department, Metropolitan Hospital, Athens, Greece
    BMC Med 8:3. 2010
  4. pmc Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model
    Aristotelis Bamias
    Department of Clinical Therapeutics, Athens University, Medical School, Athens, Greece
    BMC Cancer 10:45. 2010
  5. ncbi request reprint Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group
    D Pectasides
    Second Department of Internal Medicine Propaedeutic, Oncology Section, University General Hospital Attikon, Athens, Greece
    Lung Cancer 58:355-61. 2007
  6. ncbi request reprint Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group
    Dimosthenis Vasilios Skarlos
    Henry Dynan Hospital, Athens, Greece
    Lung Cancer 41:107-11. 2003
  7. ncbi request reprint Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer
    E Samantas
    Agii Anargyri Cancer Hospital, Athens, Greece
    Lung Cancer 23:159-68. 1999
  8. ncbi request reprint Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
    D Pectasides
    First Department of Medical Oncology, Metaxas Memorial Cancer Hospital, Piraeus Greece
    Ann Oncol 12:1417-22. 2001
  9. ncbi request reprint Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)
    George Fountzilas
    1 st Department of Internal Medicine, Oncology Section, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Cancer Invest 22:655-62. 2004
  10. ncbi request reprint Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Onco
    G Fountzilas
    Aristotle University of Thessaloniki Medical School, Greece
    Ann Oncol 10:671-6. 1999

Collaborators

Detail Information

Publications47

  1. pmc Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
    George Pentheroudakis
    Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece
    BMC Cancer 13:49. 2013
    ..We studied EGFR-axis messenger RNA (mRNA) expression and RAS, RAF, PIK3CA mutations in order to identify additional biomarkers of cetuximab efficacy...
  2. pmc Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial
    Helen Gogas
    First Department of Medicine, University of Athens, Medical School, Athens, Greece
    J Transl Med 8:108. 2010
    ..Specific CTLA-4 polymorphisms have previously shown an association with response to CTLA-4 blockade in patients with metastatic melanoma and the development of autoimmunity...
  3. pmc A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
    Dimitrios Bafaloukos
    1st Oncology Department, Metropolitan Hospital, Athens, Greece
    BMC Med 8:3. 2010
    ..This randomized phase II study was undertaken in order to compare the combination of carboplatin and pegylated liposomal doxorubicin (LD) with carboplatin and paclitaxel (CP) in this setting...
  4. pmc Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model
    Aristotelis Bamias
    Department of Clinical Therapeutics, Athens University, Medical School, Athens, Greece
    BMC Cancer 10:45. 2010
    ..We studied the prognostic significance of baseline characteristics and we compared the risk stratification with the established Memorial Sloan Kettering Cancer Center (MSKCC) model...
  5. ncbi request reprint Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group
    D Pectasides
    Second Department of Internal Medicine Propaedeutic, Oncology Section, University General Hospital Attikon, Athens, Greece
    Lung Cancer 58:355-61. 2007
    ..The purpose of this study was to evaluate the efficacy and toxicity of cisplatin, etoposide and irinotecan as first-line treatment in patients with extensive small-cell lung cancer (E-SCLC)...
  6. ncbi request reprint Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group
    Dimosthenis Vasilios Skarlos
    Henry Dynan Hospital, Athens, Greece
    Lung Cancer 41:107-11. 2003
    ..In conclusion, docetaxel-gemcitabine showed a modest response rate in chemotherapy-naive patients with ED SCLC...
  7. ncbi request reprint Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer
    E Samantas
    Agii Anargyri Cancer Hospital, Athens, Greece
    Lung Cancer 23:159-68. 1999
    ..Therapy with this regimen, though less toxic, may not be a reliable alternative in elderly patients with visceral metastases and ECOG performance status > or = 2...
  8. ncbi request reprint Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
    D Pectasides
    First Department of Medical Oncology, Metaxas Memorial Cancer Hospital, Piraeus Greece
    Ann Oncol 12:1417-22. 2001
    ..The aim of the study was to evaluate the efficacy and safety of the combination of gemcitabine and ifosfamide as a second-line treatment for advanced urothelial cancer...
  9. ncbi request reprint Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)
    George Fountzilas
    1 st Department of Internal Medicine, Oncology Section, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Cancer Invest 22:655-62. 2004
    ..This combination is the first to demonstrate a survival advantage in this group of patients. To improve on these results, we investigated a triplet, paclitaxel-gemcitabine-trastuzumab (TGH), in a phase II study...
  10. ncbi request reprint Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Onco
    G Fountzilas
    Aristotle University of Thessaloniki Medical School, Greece
    Ann Oncol 10:671-6. 1999
    ..However, this difference in response rate did not translate into a survival benefit...
  11. ncbi request reprint Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: a Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study
    J Janinis
    Third Department of Clinical Oncology, St Anargiri Cancer Center, Athens, Greece
    Ann Oncol 11:163-7. 2000
    ..The HeCOG performed a multicenter phase II study of a weekly oxaliplatin administration schedule in patients with previously treated MCC to evaluate the antitumor efficacy and toxicity of this combination...
  12. ncbi request reprint Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience
    D Pectasides
    Hellenic Cooperative Oncology Group HeCoG, Athens, Greece
    Oncology 58:286-92. 2000
    ..Because the relapse rate in the CNS and contralateral testis is quite high in most studies, prophylactic CNS treatment and radiotherapy to the other testis should be included in the management of testicular lymphoma...
  13. ncbi request reprint Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer
    G Aravantinos
    Hellenic Co operative Oncology Group, Athens, Greece
    Ann Oncol 11:607-12. 2000
    ..The prognosis of platinum resistant ovarian cancer is very poor and the treatment of choice has not been clearly defined...
  14. ncbi request reprint Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study
    E Samantas
    Agii Anargiri Cancer Hospital, Athens, Greece
    Ann Oncol 11:1395-7. 2000
    ..The objective of this multicenter phase II study was to evaluate the safety, tolerance and anti-tumour activity of Caelyx as monotherapy in patients with recurrent SCLC...
  15. ncbi request reprint Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)
    D V Skarlos
    Athens Medical Center, Greece
    Ann Oncol 12:1231-8. 2001
    ..Given these results, the Hellenic Cooperative Oncology Group (HeCOG) performed a multicenter randomized phase II study in patients with LD SCLC to evaluate the timing of HTRT (early vs. late) when given concurrently with chemotherapy...
  16. pmc A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study
    Christos A Papadimitriou
    Department of Clinical Therapeutics, Alexandra Hospital, University of Athens School of Medicine, Athens, Greece
    BMC Med 9:10. 2011
    ..In this multicenter adjuvant phase III trial, we evaluated the addition of irinotecan to weekly 5FU plus LV in patients with stage II or III colon cancer...
  17. ncbi request reprint Serum concentrations of soluble ICAM-1 and VCAM-1 in patients with colorectal cancer. Clinical implications
    K Giannoulis
    3rd Department of Surgery, AHEPA University Hospital, Thessaloniki, Greece
    Tech Coloproctol 8:s65-7. 2004
    ..In colorectal cancer (CRC), serum levels of adhesion molecules ICAM-1 and VCAM-1 increase with progressing disease. Our aim was to investigate the effect of treatment in serum ICAM-1 and VCAM-1...
  18. ncbi request reprint Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades
    A A Koumarianou
    Second Department of Internal Medicine Propaedeutic, Medical Oncology Unit, Attikon University Hospital, Athens University, Rimini 1, 12462 Athens, Greece
    Anticancer Res 27:1191-7. 2007
    ..Current controversial issues surrounding this disease, including the role of radiotherapy, positron emission tomography (PET), bone marrow biopsy and stem cell transplantation are discussed...
  19. ncbi request reprint CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group
    T Economopoulos
    Department of Medicine, Yale University, New Haven, CT, USA
    Cancer J 13:327-34. 2007
    ..In a secondary analysis we evaluated the impact of adding rituximab to CEOP-14/CEOP-21 chemotherapy...
  20. ncbi request reprint Systemic therapy in metastatic or recurrent endometrial cancer
    D Pectasides
    Second Department of Internal Medicine, Oncology Section, University of Athens, Attikon University Hospital, Haidari, 1 Rimini, Athens, Greece
    Cancer Treat Rev 33:177-90. 2007
    ..Research in better understanding the signal transduction pathways in endometrial carcinogenesis will allow the development of specific and selective molecularly targeted inhibitors...
  21. doi request reprint Merkel cell carcinoma of the skin: a retrospective study of 24 cases by the Hellenic Cooperative Oncology Group
    D Pectasides
    2nd Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, Athens, Greece
    Oncology 72:211-8. 2007
    ..The purpose of this retrospective study was to present the epidemiological and clinical characteristics of 24 patients with Merkel cell carcinoma of the skin (MCC) and their response to various therapeutic modalities...
  22. doi request reprint Carboplatin and paclitaxel in advanced or metastatic endometrial cancer
    D Pectasides
    Second Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, 1 Rimini, Athens, Greece
    Gynecol Oncol 109:250-4. 2008
    ..The purpose of this study was to evaluate the activity and toxicity of carboplatin and paclitaxel combination in advanced or recurrent endometrial carcinoma...
  23. ncbi request reprint Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG)
    D Pectasides
    Second Department of Internal Medicine, Propaeduetic, Oncology Section, University of Athens, Attikon University Hospital, Haidari, Athens, Greece
    Anticancer Res 28:1421-7. 2008
    ..Granulosa cell tumors (GCT) are rare malignant neoplasms of the ovaries with, usually, indolent biological behavior...
  24. ncbi request reprint Primary non-Hodgkin's lymphoma of the bladder: report of two cases and review of the literature
    D Pectasides
    2nd Department of Internal Medicine, Oncology Section, University of Athens, Attikon University Hospital, Rimini 1, Haidari, Athens, Greece
    J BUON 13:277-9. 2008
    ..We present herein 2 cases of non-Hodgkin's lymphoma (NHL) of the bladder and discuss their clinical-pathological features and management...
  25. ncbi request reprint Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)
    G Papaxoinis
    Second Department of Internal Medicine, University General Hospital Attikon, University of Athens, Haidari, Greece
    Ann Oncol 19:780-6. 2008
    ..The aim was to examine characteristics and treatment results of patients with mucosa-associated lymphoid tissue (MALT) non-Hodgkin's lymphomas...
  26. ncbi request reprint HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy
    D Pectasides
    Second Department of Internal Medicine Propaedeutic, Oncology Section, Attikon University Hospital, Athens, Greece
    Anticancer Res 26:647-53. 2006
    ..The utility of serological assays for HER-2/neu in such patients was also studied...
  27. ncbi request reprint Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?
    D Pectasides
    Second Department of Internal Medicine, Athens University, Attikon University Hospital, Rimini 1, Haidari, Athens, Greece
    Expert Opin Pharmacother 7:975-87. 2006
    ..In this review, the data for second-line therapy in this latter group of patients will be summarised and recommendations for their optimal management will be made...
  28. ncbi request reprint Merkel cell cancer of the skin
    D Pectasides
    Second Department of Internal Medicine, Oncology Section, University of Athens, Attikon University Hospital, Haidari, 1 Rimini, Athens, Greece
    Ann Oncol 17:1489-95. 2006
    ..Adjuvant chemotherapy (CT) should be considered as part of the initial management. In case of metastatic disease CT based on regimens used for small-cell lung cancer is the standard treatment of care...
  29. ncbi request reprint Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP
    T Economopoulos
    Second Department of Internal Medicine Propaedeutic, Athens University, Evangelismos Hospital, Greece
    Eur J Haematol 68:135-43. 2002
    ..In particular, M has less severe non-hematological toxicity...
  30. ncbi request reprint Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group
    H Gogas
    First Department of Medicine, Laiko Hospital, University of Athens, Greece
    Ann Oncol 13:1737-42. 2002
    ..To determine the activity and safety of the combination of paclitaxel and pegylated liposomal doxorubicin (Caelyx) in patients with locally advanced breast cancer...
  31. ncbi request reprint Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia
    M A Dimopoulos
    Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
    Ann Oncol 14:1299-305. 2003
    ..Although several studies have evaluated possible prognostic factors of this disease, few have focused on the survival and prognosis of symptomatic patients after the initiation of treatment...
  32. ncbi request reprint Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study
    T Economopoulos
    Second Department of Internal Medicine Propaedeutic, Evangelismos Hospital, Athens University, Athens, Greece
    Eur J Haematol 71:257-62. 2003
    ..Further follow up time is required to evaluate long-term toxicity...
  33. ncbi request reprint Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group
    G Fountzilas
    Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece
    Ann Oncol 15:1517-26. 2004
    ..To compare survival between patients with advanced breast cancer (ABC) treated with epirubicin/paclitaxel (Taxol) or paclitaxel/carboplatin (Cp) chemotherapy...
  34. ncbi request reprint Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group
    G Fountzilas
    Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Macedonia, Greece
    Ann Oncol 17:1560-7. 2006
    ..In the present randomized phase III trial we compared two new combinations containing new drugs with proven activity in phase II studies with patients with HNC...
  35. ncbi request reprint Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial
    D Pectasides
    Second Department of Internal Medicine Propaedeutic, Athens University Medical School, Attikon University Hospital, 15342 Athens, Greece
    Ann Oncol 16:294-9. 2005
    ..The aim of this study was to evaluate whether docetaxel (taxotere) treatment with or without irinotecan improved patient outcomes with similar toxicity in recurrent non-small-cell lung cancer (NSCLC)...
  36. ncbi request reprint Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group
    N Xiros
    Second Department of Internal Medicine, Propaedeutic and Research Institute, University General Hospital Attikon, University of Athens, Greece
    Ann Oncol 16:773-9. 2005
    ..In the present phase II multicenter study, we assessed the efficacy and tolerability of the combination of gemcitabine and carboplatin in patients with advanced pancreatic cancer...
  37. ncbi request reprint T-cell-rich B-cell lymphoma. Analysis of clinical features, response to treatment, survival and comparison with diffuse large B-cell lymphoma
    P Tsirigotis
    Second Department of Internal Medicine-Propaedeutic, Athens University, Evangelismos Hospital, Athens, Greece
    Oncology 61:257-64. 2001
    ....
  38. doi request reprint A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study
    H P Kalofonos
    Department of Medicine, Division of Oncology, University Hospital, University of Patras Medical School, Rion 26504, Patras, Greece
    Eur J Cancer 44:1693-700. 2008
    ..IRI added to adjuvant radiochemotherapy with LV and bolus 5FU was not shown to improve survival, whereas the incidence of severe leucopaenia was significantly higher in the IRI arm...
  39. ncbi request reprint Renal failure in multiple myeloma: incidence, correlations, and prognostic significance
    V Eleutherakis-Papaiakovou
    Department of Clinical Therapeutics, University of Athens, School of Medicine, Greece
    Leuk Lymphoma 48:337-41. 2007
    ..When corrected for stage, renal failure had no impact on survival...
  40. ncbi request reprint Analysis of p53 protein expression levels on ovarian cancer tissue microarray using automated quantitative analysis elucidates prognostic patient subsets
    A Psyrri
    Department of Medical Oncology, Yale Cancer Center, New Haven, CT 06520, USA diamando psyrri yale edu
    Ann Oncol 18:709-15. 2007
    ..Here, we sought to determine the prognostic value of p53 in ovarian cancer using a novel method of compartmentalized in situ protein analysis...
  41. ncbi request reprint Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone
    M A Dimopoulos
    Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
    Semin Oncol 30:265-9. 2003
    ..Our preliminary data indicate that this combination may be a useful salvage regimen for some patients with heavily pretreated macroglobulinemia...
  42. ncbi request reprint Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition
    A Douzenis
    Department of General Hospital Psychiatry, Athens University Medical School, Attikon Hospital, Athens, Greece
    Eur J Cancer Care (Engl) 16:289-90. 2007
    ..Olanzapine (orally disintegrating tablets) in combination with alprazolam was used successfully to relieve this terminally ill patient's anxiety and tension improving his relationship with his physicians and his daily life...
  43. ncbi request reprint Monoclonal gammopathies in B-cell non-Hodgkin's lymphomas
    T Economopoulos
    Second Department of Internal Medicine, Propaedeutic, Athens University, Evangelismos Hospital, Athens 10676, Greece
    Leuk Res 27:505-8. 2003
    ..2% of cases with B-cell NHL. IgG-MG was more frequent in cases with aggressive NHL, while IgM in cases with low risk NHL. MG was mostly associated with advanced stage and had not any prognostic significance on survival...
  44. ncbi request reprint A unique case of splenic marginal zone-cell lymphoma with synchronous clonal T-cell large granular lymphocyte proliferation: an immunologic, immunohistochemical and genotypic study
    T Papadaki
    Hemopathology Department and Immunology Laboratory, Evangelismos Hospital, Athens University, Athens, Greece
    Leuk Res 27:85-7. 2003
    ..The pathogenetic mechanisms which may be responsible for the concomitant appearance of these two rather infrequent entities in the same anatomic sites are discussed...
  45. ncbi request reprint Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
    H P Kalofonos
    Patras University Hospital, Patras, Greece
    Ann Oncol 16:869-77. 2005
    ....
  46. ncbi request reprint The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study
    E Giannoulis
    AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Acta Haematol 112:189-93. 2004
    ..The increased prevalence of HGV infection detected in patients with NHL could imply the potential participation of HGV in the pathogenesis of NHL...
  47. ncbi request reprint Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases
    T Economopoulos
    University General Hospital Attikon, Haidari, Greece
    Acta Haematol 113:97-103. 2005
    ..There were no important differences in the incidence of the remaining histological subtypes between Greece and other European countries...